Literature DB >> 19029330

CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.

Delphine Girlich1, Laurent Poirel, Patrice Nordmann.   

Abstract

In vitro selection of mutants with decreased susceptibility to ertapenem was performed using Escherichia coli and Klebsiella pneumoniae clinical strains producing either the bla(CTX-M-2), bla(CTX-M-3), bla(CTX-M-9), or bla(CTX-M-15) gene. Frequencies of mutants with decreased susceptibilities to ertapenem were similar for all beta-lactamases expressed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19029330      PMCID： PMC2630641          DOI： 10.1128/AAC.01007-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

3.  Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae.

Authors:  George A Jacoby; Debra M Mills; Nancy Chow
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Authors:  Laurent Poirel; Claire Héritier; Colette Spicq; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

5.  Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.

Authors:  Kerry J Welsh; Miriam Barlow; Fred C Tenover; James W Biddle; J Kamile Rasheed; Leigh Ann Clark; John E McGowan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.

Authors:  Eugenne Elliott; Adrian J Brink; Johan van Greune; Zia Els; Neil Woodford; Jane Turton; Marina Warner; David M Livermore
Journal:  Clin Infect Dis       Date:  2006-04-27       Impact factor: 9.079

7.  Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.

Authors:  D M Livermore; K J Oakton; M W Carter; M Warner
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 8.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

9.  Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.

Authors:  G Cornaglia; K Russell; G Satta; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism.

Authors:  Axel Fey; Stefan Eichler; Sébastien Flavier; Richard Christen; Manfred G Höfle; Carlos A Guzmán
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792
View more
  16 in total

1.  Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium.

Authors:  Patrice Nordmann; Delphine Girlich; Laurent Poirel
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

2.  Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Authors:  Spyros Pournaras; Ioulia Kristo; Georgia Vrioni; Alexandros Ikonomidis; Aggeliki Poulou; Dimitra Petropoulou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

3.  Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.

Authors:  Stephen P Hawser; Samuel K Bouchillon; Christine Lascols; Meredith Hackel; Daryl J Hoban; Robert E Badal; Neil Woodford; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

4.  Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.

Authors:  Suzanne Bialek; Jean-Philippe Lavigne; Jacqueline Chevalier; Estelle Marcon; Véronique Leflon-Guibout; Anne Davin; Richard Moreau; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

5.  Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.

Authors:  Alix Pantel; Catherine Dunyach-Remy; Christelle Ngba Essebe; Jennifer Mesureur; Albert Sotto; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine; Jean-Philippe Lavigne
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

6.  Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.

Authors:  Raphaël Lepeule; Etienne Ruppé; Patrick Le; Laurent Massias; Françoise Chau; Amandine Nucci; Agnès Lefort; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

7.  CTX-M-33, a CTX-M-15 derivative conferring reduced susceptibility to carbapenems.

Authors:  Laurent Poirel; José-Manuel Ortiz de la Rosa; Anaïs Richard; Marta Aires-de-Sousa; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

8.  Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.

Authors:  Hélène Guillon; Didier Tande; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

9.  Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae?

Authors:  Fernando Pasteran; Celeste Lucero; Rolando Soloaga; Melina Rapoport; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

10.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.

Authors:  José-Manuel Rodríguez-Martínez; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.